Ikena Oncology Ownership | Who Owns Ikena Oncology?
Ikena Oncology Ownership Summary
Ikena Oncology is owned by 5.49% institutional investors, 8.00% insiders, and 86.51% retail investors. Gilead sciences is the largest institutional shareholder, holding 4.16% of IKNA shares. Worldwide Healthcare Ord is the top mutual fund, with 3.88% of its assets in Ikena Oncology shares.
IKNA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Ikena Oncology | 5.49% | 8.00% | 86.51% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Gilead sciences | 2.01M | 4.16% | $3.29M |
| Vanguard group | 1.38M | 2.87% | $2.27M |
| Jacobs levy equity management | 424.38K | 0.88% | $700.22K |
| Atlas venture life science advisors | 5.02M | 0.87% | $6.72M |
| Blackrock | 354.84K | 0.74% | $585.49K |
| Blue owl capital lp | 4.09M | 0.71% | $5.48M |
| Bml capital management | 4.03M | 0.70% | $5.40M |
| Bvf inc/il | 4.01M | 0.69% | $5.37M |
| Renaissance | 330.20K | 0.68% | $541.53K |
| Geode capital management | 327.96K | 0.68% | $537.98K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bml capital management | 4.03M | 4.09% | $5.40M |
| Omega fund management | 2.25M | 1.95% | $3.01M |
| Blue owl capital lp | 4.09M | 1.77% | $5.48M |
| Atlas venture life science advisors | 5.02M | 1.02% | $6.72M |
| Aldebaran capital | 242.12K | 0.32% | $324.44K |
| Gilead sciences | 2.01M | 0.21% | $3.29M |
| Bvf inc/il | 4.01M | 0.19% | $5.37M |
| Orbimed advisors | 3.54M | 0.12% | $4.74M |
| Deep track capital, lp | 2.52M | 0.11% | $3.37M |
| Nea management company | 600.06K | 0.06% | $804.08K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Gilead sciences | 2.01M | 0.21% | 2.01M |
| Bml capital management | 4.03M | 4.09% | 319.30K |
| Jpmorgan chase | 155.74K | - | 154.89K |
| Citadel advisors | 244.69K | 0.00% | 85.67K |
| Ubs group | 71.86K | - | 71.78K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 354.84K | - | -1.47M |
| Acuitas investments | - | - | -449.66K |
| State street | 80.35K | - | -402.29K |
| Fny investment advisers | - | - | -231.38K |
| Verition fund management | - | - | -135.30K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Gilead sciences | 2.01M | 0.21% | 2.01M | $3.29M |
| Bnp paribas arbitrage, snc | 44.04K | - | 44.04K | $72.23K |
| Aqr capital management | 21.86K | 0.00% | 21.86K | $36.07K |
| Cubist systematic strategies | 4.84K | 0.00% | 4.84K | $7.99K |
| Macquarie group | 1.58K | - | 1.58K | $2.62K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -3.00 |
| Nisa investment advisors | -69.00 |
| Farther finance advisors | -108.00 |
| Srs capital advisors | -235.00 |
| Coldstream capital management | -525.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 42 | -8.70% | 31,763,329 | -3.01% | 5 | 0.12% | 13 | 30.00% | 10 | -50.00% |
| Mar 31, 2025 | 6 | -88.68% | 11,113,798 | -64.95% | 23 | 0.53% | 1 | -93.75% | 1 | -95.00% |
| Dec 31, 2024 | 29 | -49.12% | 14,632,033 | -48.49% | 30 | 0.88% | 9 | -50.00% | 9 | -52.63% |
| Sep 30, 2024 | 57 | -16.18% | 28,407,567 | -2.06% | 58 | 1.63% | 19 | -53.66% | 19 | 5.56% |
| Jun 30, 2024 | 68 | 21.43% | 29,003,651 | -3.64% | 60 | 1.16% | 41 | 57.69% | 18 | 5.88% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Worldwide Healthcare Ord | 1.63M | 3.88% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.05M | 2.51% | - |
| Vanguard US Total Market Shares ETF | 1.05M | 2.18% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 318.15K | 0.76% | - |
| Fidelity Extended Market Index | 130.39K | 0.31% | -340.00 |
| Bridgeway Ultra-Small Company Market | 87.50K | 0.21% | - |
| NT R2000 Value Index Fund - NL | 87.83K | 0.18% | 18.26K |
| Fidelity Total Market Index | 70.43K | 0.17% | - |
| NT R2000 Index Fund - NL | 77.70K | 0.16% | -9.21K |
| iShares Micro-Cap ETF | 67.79K | 0.14% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 24, 2022 | ORBIMED ADVISORS LLC | - | Sell | $288.27K |
| Jun 23, 2022 | ORBIMED ADVISORS LLC | - | Sell | $86.88K |
| Jun 22, 2022 | ORBIMED ADVISORS LLC | - | Sell | $237.16K |
| Jun 22, 2022 | OrbiMed Genesis GP LLC | Sell | $237.16K | |
| Jun 24, 2022 | ORBIMED ADVISORS LLC | - | Sell | $515.71K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q1 | - | - |
| 2023 Q3 | - | - |
| 2023 Q2 | - | - |
| 2023 Q1 | - | - |
| 2022 Q4 | - | - |
IKNA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools